Matches in Wikidata for { <http://www.wikidata.org/entity/Q74275368> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q74275368 description "clinical trial" @default.
- Q74275368 description "ensayu clínicu" @default.
- Q74275368 description "klinisch onderzoek" @default.
- Q74275368 description "клінічне випробування" @default.
- Q74275368 name "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 name "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 type Item @default.
- Q74275368 label "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 label "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 prefLabel "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 prefLabel "Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer" @default.
- Q74275368 P1050 Q74275368-90DE6615-3A3F-4D7E-BC63-347755A1D020 @default.
- Q74275368 P1132 Q74275368-4C832B24-465F-4CFA-AE0B-ABDFC475FB62 @default.
- Q74275368 P1476 Q74275368-F83AAA96-5E55-4A12-B37A-F5AAFF974B61 @default.
- Q74275368 P17 Q74275368-315B303D-22B0-49B5-A1C9-669FC5F60D4D @default.
- Q74275368 P2899 Q74275368-10802F58-551E-4F33-B856-5FA0E364834B @default.
- Q74275368 P3098 Q74275368-2E89BB15-F10E-48D3-B7FD-39363738E263 @default.
- Q74275368 P31 Q74275368-518634E5-B8C8-43AB-8032-E6C186FC392F @default.
- Q74275368 P4844 Q74275368-122E4301-C51A-41F8-B618-E7D13FEDF82D @default.
- Q74275368 P4844 Q74275368-182C2169-9448-4E18-94BF-CFBB4C7B9359 @default.
- Q74275368 P4844 Q74275368-D824A371-756C-48A0-A171-39C607A7BF0C @default.
- Q74275368 P580 Q74275368-0B3975FB-921D-425D-9AF0-53F1A217B769 @default.
- Q74275368 P582 Q74275368-AC8881E7-34E6-4837-9DF3-F07C29BDC615 @default.
- Q74275368 P6099 Q74275368-A398CC4E-6452-43E5-B195-8F557130DD76 @default.
- Q74275368 P8363 Q74275368-BA03D5C2-3474-4B9F-AA1F-1CAAD55C306E @default.
- Q74275368 P1050 Q33525 @default.
- Q74275368 P1132 "+34" @default.
- Q74275368 P1476 "An Investigator-Sponsored Phase 2 Single Arm Trial of Ramucirumab and Pembrolizumab in Patients With EGFR Mutant Non-Small Cell Lung Cancer" @default.
- Q74275368 P17 Q30 @default.
- Q74275368 P2899 "+18" @default.
- Q74275368 P3098 "NCT04120454" @default.
- Q74275368 P31 Q30612 @default.
- Q74275368 P4844 Q13896859 @default.
- Q74275368 P4844 Q50429626 @default.
- Q74275368 P4844 Q7290345 @default.
- Q74275368 P580 "2019-12-01T00:00:00Z" @default.
- Q74275368 P582 "2021-12-31T00:00:00Z" @default.
- Q74275368 P6099 Q42824440 @default.
- Q74275368 P8363 Q78089383 @default.